An Open Letter from Concerned Cannabis Clinicians

Dear Editors of The New York Times,

In your recent article titled "As America’s Marijuana Use Grows, So Do the Harms," published on October 4, 2024, you highlight potential risks associated with cannabis use. While we acknowledge that cannabis, like any substance, can pose risks for certain individuals, we are concerned that your article presents a one-sided perspective that overlooks the substantial benefits medical cannabis provides to countless patients.

As practicing clinicians, we witness daily the transformative effects of medical cannabis on our patients' lives. It effectively manages chronic pain, reduces seizures in epilepsy, alleviates symptoms of multiple sclerosis, and mitigates chemotherapy-induced nausea and vomiting. Under professional supervision, patients use cannabis responsibly, enhancing their quality of life without the severe side effects often associated with traditional medications.

Furthermore, medical cannabis can play a significant role in addressing the opioid crisis by offering a safer alternative for pain management, potentially reducing opioid dependence and overdose deaths. We also believe that concerns about cannabis use disorder and mental health need to be contextualized within a broader understanding of responsible medical use versus misuse.

We urge you to consider a more balanced narrative that reflects both the potential risks and the significant therapeutic advantages of cannabis. By fostering an open and informed dialogue, we can reduce stigma, enhance patient outcomes, and inform policy development that prioritizes patient safety and public health.

 
Detailed Discussion:

_____________________________

1. The Therapeutic Power of Medical Cannabis

Chronic Pain Relief:

Medical cannabis has been shown to alleviate chronic pain, improving the quality of life for patients with conditions such as arthritis, fibromyalgia, and neuropathy.

Evidence: A study published in the Journal of Pain found that cannabis use led to a significant reduction in chronic pain symptoms and improved sleep quality.
Patient Impact: Patients often report decreased reliance on opioids and other pain medications with undesirable side effects.
Epilepsy Management:

Cannabidiol (CBD), a non-intoxicating compound in cannabis, effectively reduces seizures in patients with treatment-resistant epilepsy.

Evidence: Clinical trials reported in The New England Journal of Medicine demonstrated that CBD significantly reduced seizure frequency in children with Dravet syndrome.
Patient Impact: Families have witnessed life-changing improvements, with some children experiencing their first seizure-free days.
Multiple Sclerosis Symptom Control:

Cannabis-derived medications ease muscle spasticity, pain, and sleep disturbances in multiple sclerosis patients.

Evidence: Research in The Lancet Neurology indicated that patients using cannabis extracts showed greater relief from muscle stiffness than those receiving a placebo.
Patient Impact: Improved mobility and reduced muscle spasms enhance independence and daily functioning.
Cancer Treatment Support:

Cannabis mitigates chemotherapy-induced nausea and vomiting, a common side effect that can lead to malnutrition and treatment discontinuation.

Evidence: The American Cancer Society acknowledges that cannabis can help patients tolerate chemotherapy by reducing nausea and improving appetite.
Patient Impact: Patients maintain better nutritional status and are more likely to complete their cancer treatment regimens.

2. Responsible Use Under Medical Supervision

Personalized Treatment Plans:

Clinicians tailor cannabis therapy to individual patient needs, selecting appropriate strains, dosages, and delivery methods.

Approach: Assessment of medical history, current medications, and specific symptoms ensures safe and effective use.
Benefit: Customized plans maximize therapeutic effects while minimizing potential adverse reactions.
Continuous Monitoring:

Regular follow-ups allow healthcare providers to monitor progress, adjust treatment, and address any concerns promptly.

Approach: Scheduled appointments and open communication channels facilitate ongoing evaluation.
Benefit: Early detection of issues enhances safety and optimizes outcomes.
Patient Education:

Educating patients about potential side effects, interactions, and responsible use is integral to medical cannabis therapy.

Approach: Informative discussions and written materials empower patients with knowledge.
Benefit: Informed patients are better equipped to use cannabis safely and effectively.
3. Reexamining Cannabis Use Disorder (CUD)

Understanding Tolerance and Dependence:

Physiological adaptation to substances, leading to tolerance or withdrawal symptoms, is common with many medications.

Context: Antidepressants, benzodiazepines, and even caffeine can produce similar effects without being labeled as misuse.
Insight: Tolerance alone does not indicate addiction or problematic use.
Context Matters:

Consistent cannabis use may reflect effective management of chronic symptoms rather than compulsive behavior.

Example: A patient with chronic pain may use cannabis regularly to maintain functionality and quality of life.
Insight: Responsible medical use should be differentiated from misuse.
Avoiding Overgeneralization:

Equating medical cannabis patients with those experiencing substance abuse issues overlooks the nuances of patient care.

Concern: Overpathologizing can stigmatize patients and discourage them from seeking beneficial treatments.
Recommendation: Diagnostic criteria should consider intent, context, and overall functioning.

4. Addressing Mental Health Considerations

Cannabis as a Therapeutic Option:

For many patients, cannabis alleviates symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD).

Evidence: Studies have shown that certain cannabis strains can reduce anxiety levels and improve mood.
Patient Impact: Improved mental health leads to better overall well-being and daily functioning.
Holistic Assessment:

Mental health conditions are multifactorial; cannabis is seldom the sole cause of psychiatric disorders.

Context: Genetic predisposition, environmental factors, and personal history play significant roles.
Insight: Careful patient evaluation helps identify those who may benefit from cannabis therapy versus those who may be at risk.
Need for Continued Research:

Ongoing studies are essential to deepen our understanding of cannabis's impact on mental health.

Action: Encourage and support research initiatives that explore both benefits and risks.
Benefit: Evidence-based guidelines can enhance safe prescribing practices.

5. Cannabis's Role in Combating the Opioid Crisis

Reducing Opioid Dependence:

Medical cannabis offers a safer alternative for pain management, potentially decreasing reliance on opioids.

Evidence: Patients report significant pain relief with cannabis, allowing them to reduce or eliminate opioid use.
Impact: Lower risk of addiction and overdose associated with opioids.
Lowering Overdose Rates:

Studies indicate that states with legal medical cannabis programs have seen reductions in opioid-related overdose deaths.

Reference: Research published in JAMA Internal Medicine found a 25% lower opioid overdose mortality rate in states with medical cannabis laws.
Insight: Access to cannabis may contribute to public health efforts in reducing overdose fatalities.
Enhancing Pain Management Strategies:

Incorporating cannabis into multidisciplinary pain management can improve patient outcomes.

Approach: Combining cannabis with physical therapy, counseling, and other modalities.
Benefit: Holistic care addresses multiple aspects of pain, enhancing efficacy.

6. Advocating for Informed Policy and Education

Evidence-Based Regulations:

Establishing standards for product quality, potency, and labeling protects patients and consumers.

Recommendation: Implement testing requirements for contaminants and accurate THC/CBD content.
Benefit: Ensures safety and consistency in medical cannabis products.
Professional Training Programs:

Educating healthcare providers about cannabis enhances patient care and informed decision-making.

Action: Incorporate cannabis education into medical curricula and continuing education.
Benefit: Clinicians are better equipped to counsel patients and manage therapy.
Public Awareness Campaigns:

Providing accurate information empowers individuals to make educated choices about cannabis use.

Strategy: Develop resources that present balanced perspectives on risks and benefits.
Outcome: Informed public can engage in responsible use and policy discussions.
Facilitating Research:

Rescheduling cannabis at the federal level would remove barriers to scientific study.

Advocacy: Support legislative efforts to reclassify cannabis from Schedule I.
Benefit: Enables comprehensive research into therapeutic potentials and safety profiles.
 
Conclusion: Embracing a Nuanced Perspective

Cannabis is a complex substance with the capacity for both healing and harm. A nuanced, evidence-based discourse is crucial for harnessing its benefits while mitigating risks. By fostering an open and informed dialogue, we can:

Reduce Stigma:

Encouraging acceptance of medical cannabis improves patient access to necessary treatments without fear of judgment.
Enhance Patient Outcomes:

Sharing positive clinical experiences and evidence supports broader therapeutic applications and patient trust.
Inform Policy Development:

Balanced reporting influences thoughtful legislation that prioritizes patient safety, research advancement, and public health.
We invite collaboration with media outlets, policymakers, and healthcare professionals to advance understanding and optimize the role of cannabis in modern medicine. Together, we can ensure that patients receive the comprehensive care they deserve.

Sincerely,

List of Physicians, Practicing Cannabis Clinicians, and Members of The Cannabis Community

 
References:

National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.

Whiting, P. F., Wolff, R. F., Deshpande, S., et al. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 313(24), 2456–2473.

Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673.

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014). Adverse Health Effects of Marijuana Use. New England Journal of Medicine, 370(23), 2219–2227.

Lucas, P., & Walsh, Z. (2017). Medical Cannabis Access, Use, and Substitution for Prescription Opioids and Other Substances: A Survey of Authorized Medical Cannabis Patients. International Journal of Drug Policy, 42, 30–35.

Link to read these references
 
Note to Readers:

We recognize that cannabis use is a topic of significant interest and debate. Our intention is to contribute constructively to this conversation by sharing clinical experiences and highlighting evidence-based perspectives. We encourage readers to explore the referenced studies and consult healthcare professionals to make informed decisions about cannabis use.

 
Summary of Takeaway Points:

Medical cannabis offers significant therapeutic benefits for various conditions, improving patient quality of life.
Under professional supervision, patients use cannabis responsibly, reducing reliance on more harmful medications.
Concerns about cannabis use disorder and mental health need to be contextualized within responsible medical use.
Medical cannabis can play a role in addressing the opioid crisis by offering a safer alternative for pain management.
Balanced, evidence-based discourse and informed policies are essential to maximize benefits and minimize risks.
Collaboration among media, policymakers, and healthcare professionals is crucial for advancing understanding and optimizing cannabis's role in medicine.